Literature DB >> 24052472

Perfusion machines for liver transplantation: technology and multifunctionality.

Michele Rubbini1.   

Abstract

The reliability of machine perfusion (alternative to static cold storage) for the preservation of liver for transplantation has been well investigated in experimental models, by taking into account the temperature, oxygenation, flow, pressure, and settings of the machine or proposed circuit. Machine perfusion is considered by many researchers as a valid method for preserving organs. While circuits or machines for preservation have been described, no agreement has been reached concerning how these devices should be developed. The machines proposed to date are considered here to identify the technical and functional features necessary for a machine to have multifunctionality and adaptability to cater all the needs of preservation, according to the type and features of the liver to be transplanted, including marginal livers. The need to establish a uniform method for the use of this machine is also emphasized, to achieve a clinical protocol for its use.

Mesh:

Year:  2013        PMID: 24052472     DOI: 10.1007/s13304-013-0234-z

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  62 in total

Review 1.  Hypothermic organ preservation by static storage methods: Current status and a view to the future.

Authors:  Jonathan F McAnulty
Journal:  Cryobiology       Date:  2009-06-16       Impact factor: 2.487

2.  Organ Preservation: Current Concepts and New Strategies for the Next Decade.

Authors:  Edgardo E Guibert; Alexander Y Petrenko; Cecilia L Balaban; Alexander Y Somov; Joaquín V Rodriguez; Barry J Fuller
Journal:  Transfus Med Hemother       Date:  2011-03-21       Impact factor: 3.747

3.  Orthotopic homotransplantation of the human liver.

Authors:  T E Starzl; C G Groth; L Brettschneider; I Penn; V A Fulginiti; J B Moon; H Blanchard; A J Martin; K A Porter
Journal:  Ann Surg       Date:  1968-09       Impact factor: 12.969

4.  Twenty-four hour liver preservation by the use of continuous pulsatile perfusion and hyperbaric oxygen.

Authors:  M Slapak; R A Wigmore; L D MacLean
Journal:  Transplantation       Date:  1967-07       Impact factor: 4.939

5.  Successful seventeen-hour preservation and transplantation of human-cadaver kidney.

Authors:  F O Belzer; B S Ashby; P F Gulyassy; M Powell
Journal:  N Engl J Med       Date:  1968-03-14       Impact factor: 91.245

6.  Subnormothermic machine perfusion at both 20°C and 30°C recovers ischemic rat livers for successful transplantation.

Authors:  Herman Tolboom; Maria-Louisa Izamis; Nripen Sharma; Jack M Milwid; Basak Uygun; François Berthiaume; Korkut Uygun; Martin L Yarmush
Journal:  J Surg Res       Date:  2011-03-29       Impact factor: 2.192

7.  Excorporeal normothermic machine perfusion resuscitates pig DCD livers with extended warm ischemia.

Authors:  Hongzhi Xu; Tim Berendsen; Karen Kim; Alejandro Soto-Gutiérrez; Francios Bertheium; Martin L Yarmush; Martin Hertl
Journal:  J Surg Res       Date:  2011-10-24       Impact factor: 2.192

8.  Hypothermic machine preservation in human liver transplantation: the first clinical series.

Authors:  J V Guarrera; S D Henry; B Samstein; R Odeh-Ramadan; M Kinkhabwala; M J Goldstein; L E Ratner; J F Renz; H T Lee; R S Brown; J C Emond
Journal:  Am J Transplant       Date:  2009-12-02       Impact factor: 8.086

9.  Machine perfusion or cold storage in deceased-donor kidney transplantation.

Authors:  Cyril Moers; Jacqueline M Smits; Mark-Hugo J Maathuis; Jürgen Treckmann; Frank van Gelder; Bogdan P Napieralski; Margitta van Kasterop-Kutz; Jaap J Homan van der Heide; Jean-Paul Squifflet; Ernest van Heurn; Günter R Kirste; Axel Rahmel; Henri G D Leuvenink; Andreas Paul; Jacques Pirenne; Rutger J Ploeg
Journal:  N Engl J Med       Date:  2009-01-01       Impact factor: 91.245

10.  Oxygen persufflation as adjunct in liver preservation (OPAL): study protocol for a randomized controlled trial.

Authors:  Thomas Minor; Carolin Pütter; Anja Gallinat; Claudia Ose; Gernot Kaiser; Andre Scherag; Jürgen Treckmann; Andreas Paul
Journal:  Trials       Date:  2011-10-28       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.